Clark A. and collaborators have recently found high MW forms of ApoA-I in urine of paediatric FSGS patients in relapse9, a fact that reinforces the idea that Apo-AI and/or modifications on this lipoprotein may have a role in FSGS development10. This evidence concerns the gene APOA1 and focal segmental glomerulosclerosis.